RETeval™ is a handheld DR screening device that enables virtually any health care provider to screen for sight-threatening DR in less than three minutes per patient with no dilation regardless of ...

GAITHERSBURG, Md., April 13, 2018 /PRNewswire/ -- LKC Technologies, the worldwide leader in visual electrophysiology, today announced its partnership with US Retina, one of the largest associations of ...

Point-of-care diagnostics company Welch Allyn and visual electrophysiology player LKC Technologies have signed an exclusive partnership for the former to distribute the latter's RETeval DR device, ...

GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire/ -- Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the ...

GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ -- A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval(R) based visual ...

More than 400 diabetic patients have been evaluated using the RETeval® a handheld diabetic retinopathy screening device, announced LKC Technologies. RETeval lets a healthcare provider screen a ...

LKC manufactures electrophysiology testing devices used as an aid in the diagnosis and management of retinal and optic nerve diseases With headquarters in Toronto and Park City, Utah, DWHP is a ...

TORONTO and PARK CITY, Utah, June 12, 2023 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, announces the completion of its investment in LKC Technologies, ...

GAITHERSBURG, Md., July 14, 2022 /PRNewswire/ --LKC Technologies, a leader in the electroretinography device market, announces the hiring of two seasoned industry professionals to lead their strategic ...